Softwr

Healthcare · head to head

Cerner vs Therapixel

Cerner logo

Cerner

Healthcare

Health information technology solutions for healthcare organizations

From
On request
Rated
-
Full reviewWebsite
Therapixel logo

Therapixel

Healthcare

French mammography AI with FDA clearances for 2D and tomosynthesis breast screening

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Cerner no published pricing on vendor website; enterprise healthcare software requires custom quotes; Therapixel european and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • They diverge on capability: Cerner covers Electronic Health Records, Therapixel covers MammoScreen 2D.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Cerner and Therapixel actually diverge.

Attributes where Cerner and Therapixel differ
AttributeCernerTherapixel
PlatformsWeb, iOS, AndroidWeb
Founded1979Unknown

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Cerner

  • Electronic Health Records
  • Revenue Cycle
  • Population Health
  • Patient Engagement
  • HL7
  • FHIR
  • Lab Systems
  • HIPAA

Only in Therapixel

  • MammoScreen 2D
  • MammoScreen DBT
  • One to ten suspicion score
  • Summary report
  • Workstation and PACS delivery
  • Reading workflow configurations

What people use each for

The jobs each tool is most often brought in to do.

Cerner

  • Hospital and acute care EHR for chart review and clinical documentationnot Therapixel
  • Mobile clinical access for physicians and care teams on point-of-care devicesnot Therapixel

Therapixel

  • A European breast screening programme running mandatory double reading that wants to evaluate AI as a concurrent or second reader within what national guidance permitsnot Cerner
  • An American breast centre that has moved to tomosynthesis and needs reading support on DBT specifically, which Therapixel holds a clearance fornot Cerner
  • A screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own thresholdnot Cerner
  • A radiology group evaluating multiple mammography AI vendors head to head on their own historic case set before committingnot Cerner

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Cerner

  • No published pricing on vendor website; enterprise healthcare software requires custom quotes

Therapixel

  • European and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • MammoScreen does mammography only, so a hospital wanting AI across head CT, chest and breast needs several vendors and several PACS integrations, or an orchestration layer bought from someone else.
  • Therapixel is a small French company competing against Hologic and iCAD, which have incumbency inside the mammography reading workstation, so integration into an American breast centre is more work than it is for the workstation vendor own AI.
  • Detection performance is sensitive to the mammography unit vendor and acquisition protocol, so published results do not transfer between estates and each site needs local validation it must fund itself.
  • Whether AI can substitute for one of two human readers is a national workforce and liability question, not a product capability, so the labour saving that justifies the purchase in one country is not permitted in another.

Pricing, plan by plan

Cerner

On request

No published plan breakdown. See the Cerner review.

Therapixel

On request
  • MammoScreen$undefined/year
    • Priced per examination or by annual screening volume
    • 2D and tomosynthesis licensed by the versions cleared for each
    • Cloud or on premises deployment quoted differently

Which should you pick?

Choose Cerner if

  • You need electronic health records.
  • You work on Web, iOS, Android.
  • You also want revenue cycle.
Cerner review

Choose Therapixel if

  • You need mammoscreen 2d.
  • You also want mammoscreen dbt.
Therapixel review

Questions people ask

Is Cerner or Therapixel better?
Neither clearly leads. Cerner starts at On request and Therapixel at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Cerner or Therapixel?
Cerner starts at On request and Therapixel at On request.
Does Cerner or Therapixel run on more platforms?
Cerner runs on Web, iOS, Android. Therapixel runs on Web.
What is Cerner best used for?
Cerner is most often used for hospital and acute care ehr for chart review and clinical documentation, mobile clinical access for physicians and care teams on point-of-care devices. Of those, hospital and acute care ehr for chart review and clinical documentation and mobile clinical access for physicians and care teams on point-of-care devices are not what Therapixel is typically brought in for.
What can Cerner do that Therapixel cannot?
Cerner covers Electronic Health Records, Revenue Cycle, Population Health, Patient Engagement. Therapixel covers MammoScreen 2D, MammoScreen DBT, One to ten suspicion score, Summary report.

Answered from the vendors’ own pages

Cerner: Does Cerner publish its pricing?

No, Cerner does not publish standard pricing. As an enterprise healthcare EHR vendor (now acquired by Oracle), pricing is customized per healthcare organization based on size, bed capacity, modules required, and implementation scope. Contact Oracle Health for pricing.

Source
Therapixel: Is MammoScreen FDA cleared?

Yes. It holds 510(k) clearance K192854 for two dimensional mammography from July 2020, a November 2021 clearance for digital breast tomosynthesis, and two further clearances in October 2024 for later versions.

Therapixel: Is it CE marked?

Yes, but European buyers should ask specifically for the current certificate under the Medical Device Regulation and its expiry date, because this class of diagnostic AI moved to a higher classification under MDR.

Therapixel: What does the one to ten score mean?

It is a graded suspicion score per finding and per study, designed to be integrated alongside a radiologist BI-RADS assessment rather than treated as a positive or negative result.

Therapixel: Does it cover anything besides mammography?

No. It is a mammography product only, including tomosynthesis. Other body regions need a different vendor.

Share

Related pages

More on Cerner

More on Therapixel

Keep looking

Other head to heads